877 related articles for article (PubMed ID: 18565187)
1. A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index.
Berth-Jones J; Thompson J; Papp K;
Br J Dermatol; 2008 Aug; 159(2):407-12. PubMed ID: 18565187
[TBL] [Abstract][Full Text] [Related]
2. A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment.
Berth-Jones J; Grotzinger K; Rainville C; Pham B; Huang J; Daly S; Herdman M; Firth P; Hotchkiss K
Br J Dermatol; 2006 Oct; 155(4):707-13. PubMed ID: 16965419
[TBL] [Abstract][Full Text] [Related]
3. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment.
Bożek A; Reich A
Adv Clin Exp Med; 2017 Aug; 26(5):851-856. PubMed ID: 29068583
[TBL] [Abstract][Full Text] [Related]
4. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis.
Chandran V; Gottlieb A; Cook RJ; Duffin KC; Garg A; Helliwell P; Kavanaugh A; Krueger GG; Langley RG; Lynde C; McHugh N; Mease P; Olivieri I; Rahman P; Rosen CF; Salvarani C; Thaci D; Toloza SM; Wong MY; Zhou QM; Gladman DD
Arthritis Rheum; 2009 Sep; 61(9):1235-42. PubMed ID: 19714610
[TBL] [Abstract][Full Text] [Related]
5. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment.
Langley RG; Ellis CN
J Am Acad Dermatol; 2004 Oct; 51(4):563-9. PubMed ID: 15389191
[TBL] [Abstract][Full Text] [Related]
6. Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased.
Jacobson CC; Kimball AB
Br J Dermatol; 2004 Aug; 151(2):381-7. PubMed ID: 15327545
[TBL] [Abstract][Full Text] [Related]
7. Measuring disease activity and damage in discoid lupus erythematosus.
Wahie S; McColl E; Reynolds NJ; Meggitt SJ
Br J Dermatol; 2010 May; 162(5):1030-7. PubMed ID: 20199547
[TBL] [Abstract][Full Text] [Related]
8. Interobserver reliability of the Nail Psoriasis Severity Index.
Aktan S; Ilknur T; Akin C; Ozkan S
Clin Exp Dermatol; 2007 Mar; 32(2):141-4. PubMed ID: 17137477
[TBL] [Abstract][Full Text] [Related]
9. Method of assessing involved facial areas: rule of fours.
Yoon HS; Choi JW; Youn JI
Br J Dermatol; 2008 May; 158(5):1022-8. PubMed ID: 18341660
[TBL] [Abstract][Full Text] [Related]
10. The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison.
Gottlieb AB; Chaudhari U; Baker DG; Perate M; Dooley LT
J Drugs Dermatol; 2003 Jun; 2(3):260-6. PubMed ID: 12848110
[TBL] [Abstract][Full Text] [Related]
11. A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients.
Louden BA; Pearce DJ; Lang W; Feldman SR
Dermatol Online J; 2004 Oct; 10(2):7. PubMed ID: 15530297
[TBL] [Abstract][Full Text] [Related]
12. A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis.
Carlin CS; Feldman SR; Krueger JG; Menter A; Krueger GG
J Am Acad Dermatol; 2004 Jun; 50(6):859-66. PubMed ID: 15153885
[TBL] [Abstract][Full Text] [Related]
13. Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension.
van de Kerkhof PC; Segaert S; Lahfa M; Luger TA; Karolyi Z; Kaszuba A; Leigheb G; Camacho FM; Forsea D; Zang C; Boussuge MP; Paolozzi L; Wajdula J
Br J Dermatol; 2008 Nov; 159(5):1177-85. PubMed ID: 18673365
[TBL] [Abstract][Full Text] [Related]
14. Measurement of the severity of rosacea.
Bamford JT; Gessert CE; Renier CM
J Am Acad Dermatol; 2004 Nov; 51(5):697-703. PubMed ID: 15523346
[TBL] [Abstract][Full Text] [Related]
15. Inter-observer reliability of the PASI in a clinical setting.
Cabrera S; Chinniah N; Lock N; Cains GD; Woods J
Australas J Dermatol; 2015 May; 56(2):100-2. PubMed ID: 25753553
[TBL] [Abstract][Full Text] [Related]
16. Tele-assessment of Psoriasis Area and Severity Index: a study of the accuracy of digital image capture.
Singh P; Soyer HP; Wu J; Salmhofer W; Gilmore S
Australas J Dermatol; 2011 Nov; 52(4):259-63. PubMed ID: 22070699
[TBL] [Abstract][Full Text] [Related]
17. The interrater and intrarater reliability of the Modified Ashworth Scale in the assessment of muscle spasticity: limb and muscle group effect.
Ansari NN; Naghdi S; Arab TK; Jalaie S
NeuroRehabilitation; 2008; 23(3):231-7. PubMed ID: 18560139
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of the Dermatomyositis Skin Severity Index.
Carroll CL; Lang W; Snively B; Feldman SR; Callen J; Jorizzo JL
Br J Dermatol; 2008 Feb; 158(2):345-50. PubMed ID: 18067478
[TBL] [Abstract][Full Text] [Related]
19. Application of machine vision to assess involved surface in patients with psoriasis.
Savolainen L; Kontinen J; Röning J; Oikarinen A
Br J Dermatol; 1997 Sep; 137(3):395-400. PubMed ID: 9349336
[TBL] [Abstract][Full Text] [Related]
20. Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort.
Walsh JA; McFadden M; Woodcock J; Clegg DO; Helliwell P; Dommasch E; Gelfand JM; Krueger GG; Duffin KC
J Am Acad Dermatol; 2013 Dec; 69(6):931-7. PubMed ID: 24054760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
